首頁 > 市場調查報告書 > 製藥

婦科治療

激素替代療法市場：按療法類型、給藥途徑、應用、分銷渠道、地區 - 規模、份額、前景和機會分析，2022-2030

市場調查報告書

商品編碼

1110223

激素替代療法市場：按療法類型、給藥途徑、應用、分銷渠道、地區 - 規模、份額、前景和機會分析，2022-2030

Hormone Replacement Therapy Market, by Therapy Type, by Route of Administration, by Application, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

出版日期: 2022年07月26日 | 出版商:

Coherent Market Insights | 英文 151 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

激素替代療法 (HRT) 有助於在絕經期間或接近絕經期間平衡雌激素和孕激素水平。激素替代療法 (HRT) 是一種緩解更年期症狀的治療方法。它取代了隨著您接近更年期而下降的荷爾蒙。在更年期，雌激素水平下降。一些女性會出現不適症狀，例如潮熱和陰道乾燥。 HRT（也稱為激素療法、更年期激素療法和雌激素替代療法）是針對更年期症狀最有效的治療方法。激素替代療法包括緩解潮熱和盜汗，良好的睡眠，緩解陰道乾澀和瘙癢，緩解性交疼痛，預防骨質疏鬆引起的骨折，預防心髒病，預防癡呆。要有效。

市場動態

由於各種製造商用於激素替代療法的仿製藥增加，預計市場的數量和價值將增長。例如，梯瓦製藥工業有限公司於 2017 年 8 月 18 日在美國.在市場上推出。溶液通過帶有腋下塗藥器的計量泵輸送。此外，2022 年 4 月，製藥公司 Lupin Limited 在美國市場推出了妊娠預防藥物“Merzee 膠囊”。 Merzee（醋酸炔諾酮和炔雌醇膠囊，富馬酸亞鐵膠囊），1mg/20mcg，是 Allergan Pharmaceuticals 的 Teitula 膠囊的仿製藥。印度藥品製造商 Lupin 與專門從事複雜仿製藥開發、製造和採購的 Slaybak Pharma LLC 簽訂了獨家許可、營銷和分銷協議，並已在美國市場推出。

本研究的主要特點

本報告對全球激素替代療法市場進行了深入分析，提供了以 2021 年為基準年的預測期（2022-2030 年）的市場規模和復合年增長率 (CAGR%)。
解釋不同細分市場的潛在收入機會，並描述該市場具有吸引力的投資建議矩陣。
該研究還提供了有關市場驅動因素、抑制因素、機會、新產品發布或批准、市場趨勢、區域前景以及主要參與者採用的競爭策略的重要見解。
根據公司亮點、產品組合、關鍵亮點、財務業績和戰略等參數，對全球激素替代療法市場的主要參與者進行簡介。
本研究涵蓋的主要公司包括諾華公司、雅培公司、邁蘭公司、默克公司、拜耳公司、輝瑞公司、諾和諾德 A/S、QuatRx 製藥公司、梯瓦製藥工業有限公司、安進公司。和禮來公司
本報告中的見解將使營銷人員和企業高管能夠就未來的產品發布、類型升級、市場擴張和營銷策略做出明智的決策。獎品
全球激素替代療法市場報告針對該行業的各種利益相關者，包括投資者和供應商、產品製造商、分銷商、新進入者和財務分析師。牙齒，
通過分析全球激素替代療法市場中使用的各種策略矩陣，可以輕鬆做出決策。

內容

第 1 章目的和先決條件

調查目的
先決條件
縮寫說明

第2章市場展望

舉報內容
- 市場定義和範圍
執行摘要
- 市場快照：按治療類型
- 按管理途徑劃分的市場概況
- 市場快照：按應用
- 市場快照：按分銷渠道
- 市場概況：按地區劃分
連貫的機會圖 (COM)

第 3 章市場動態、法規和趨勢分析

市場動態
- 驅動程序
- 約束因素
- 市場機會
影響分析
市場趨勢
近期趨勢
收購和合作方案
技術概述
監管場景
價格分析
PEST 分析

第 4 章全球激素替代療法市場 - 冠狀病毒 (COVID-19) 大流行的影響

整體影響
政府舉措
COVID-19 對市場的影響

第 5 章全球激素替代療法市場，按療法類型，2017-2030 年

雌激素替代療法
人類生長激素 (HGH) 替代療法
甲狀腺替代療法
雄性激素替代療法

第 6 章全球激素替代療法市場：按給藥途徑，2017-2030 年

口語
腸胃外給藥
其他

第 7 章全球激素替代療法市場：按應用分列，2017-2030 年

甲狀腺功能減退
男性性腺機能減退
生長激素缺乏症
更年期
其他

第 8 章全球激素替代療法市場：2017-2030 年分銷渠道

醫院藥房
零售藥房
在線藥店

第 9 章按地區分列的全球激素替代療法市場，2017-2030

北美
美國
加拿大
拉丁美洲
巴西
墨西哥
阿根廷
其他拉丁美洲地區
歐洲
英國
德國
意大利
法國
西班牙
俄羅斯
其他歐洲
亞太地區
中國
印度
日本
東盟
澳大利亞
韓國
其他亞太地區
中東
海合會
以色列
其他中東地區
非洲
北非
中非
南非

第 10 章競爭格局

熱圖分析
公司簡介
- Novartis AG
- Abbott Laboratories
- Mylan NV
- Merck KgaA
- Bayer AG
- Pfizer Inc.
- Novo Nordisk A/S
- QuatRx Pharmaceuticals
- Teva Pharmaceutical Industries Ltd.
- Amgen, Inc.
- Eli Lilly and Company

第11章章節

參考文獻
調查手法

簡介目錄

Product Code: CMI2079

Hormone replacement therapy (HRT) can help balance estrogen and progesterone levels during or near menopause. Hormone replacement therapy (HRT) is a treatment to relieve symptoms of menopause. It replaces hormones that are at a lower level as approach the menopause. During menopause, estrogen levels fall. Some women get uncomfortable symptoms such as hot flashes and vaginal dryness. HRT (also known as hormone therapy, menopausal hormone therapy, and estrogen replacement therapy) is the most effective treatment for menopause symptoms. The benefits of hormone replacement therapy are that it relieves hot flashes and night sweats, helps sleep better, eases vaginal dryness and itching, makes sexual intercourse less painful, helps prevent fractures caused by osteoporosis (thinning bones), make some women less likely to have heart disease, and lowers chances of dementia.

Market Dynamics

Rising number of generic versions of hormone replacement therapies by various manufacturers would drive growth of market in terms of volume and value. For instance, Teva Pharmaceutical Industries Ltd. launched the generic Axiron1 (testosterone) topical solution CIII, 30 mg/1.5 mL, in the U.S. on August 18, 2017 to treat adult males who have low or no testosterone due to certain medical conditions. This solution was supplied in a metered dose pump with an underarm applicator. Moreover, in April 2022, Lupin Limited, a pharmaceutical company, launched Merzee capsules, a medication used to prevent pregnancy, in the U.S. market. Merzee (norethindrone acetate and ethinyl estradiol capsules and ferrous fumarate capsules), 1 mg/20 mcg is a generic equivalent of Allergan Pharmaceuticals' Taytulla capsules. The Lupin Limited, India-based drug maker had launched the product in the U.S. market under exclusive license, marketing and distribution agreement with Slayback Pharma LLC, a specialty pharmaceutical company focused on developing, manufacturing and sourcing of complex generic pharmaceutical products from Lupin Ltd.

Key features of the study:

This report provides an in-depth analysis of the global hormone replacement therapy market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global hormone replacement therapy market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Novartis AG, Abbott Laboratories, Mylan NV, Merck KgaA, Bayer AG, Pfizer Inc., Novo Nordisk A/S, QuatRx Pharmaceuticals, Teva Pharmaceutical Industries Ltd., Amgen, Inc., and Eli Lilly and Company
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global hormone replacement therapy market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global hormone replacement therapy market

Detailed Segmentation:

Global Hormone Replacement Therapy Market, By Therapy Type:
- Estrogen Replacement Therapy
- Human Growth Hormone (HGH) Replacement Therapy
- Thyroid Replacement Therapy
- Testosterone Replacement Therapy
Global Hormone Replacement Therapy Market, By Route Of Administration:
- Oral
- Parenteral
- Others
Global Hormone Replacement Therapy Market, By Application:
- Hypothyroidism
- Male Hypogonadism
- Growth Hormone Deficiency
- Menopause
- Others
Global Hormone Replacement Therapy Market, By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Global Hormone Replacement Therapy Market, By Region:
- North America
  - By Country
- U.S.
- Canada
- Latin America
  - By Country
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
  - By Country
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
  - By Country
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
  - By Country
- GCC
- Israel
- Rest of Middle East
- Africa
  - By Region/Country
- South Africa
- Central Africa
- North Africa
Company Profiles
- Novartis AG*
  - Company Highlights
  - Products Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Abbott Laboratories
- Mylan NV
- Merck KgaA
- Bayer AG
- Pfizer Inc.
- Novo Nordisk A/S
- QuatRx Pharmaceuticals
- Teva Pharmaceutical Industries Ltd.
- Amgen, Inc.
- Eli Lilly and Company

"*" marked represents similar segmentation in other categories in the respective section.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Therapy Type
- Market Snapshot, By Route Of Administration
- Market Snapshot, By Application
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Market Trends
Recent Developments
Acquisitions and Partnerships Scenario
Technology Overview
Regulatory Scenario
Pricing Analysis
PEST Analysis

4. Global Hormone Replacement Therapy Market- Impact of Coronavirus (Covid-19) Pandemic

Overall Impact
Government Initiatives
COVID-19 Impact on the market

5. Global Hormone Replacement Therapy Market, By Therapy Type, 2017 - 2030, (US$ Million)

Overview
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
Estrogen Replacement Therapy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Human Growth Hormone (HGH) Replacement Therapy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Thyroid Replacement Therapy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Testosterone Replacement Therapy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

6. Global Hormone Replacement Therapy Market, By Route Of Administration, 2017 - 2030, (US$ Million)

Overview
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
Oral
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Parenteral
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

7. Global Hormone Replacement Therapy Market, By Application, 2017 - 2030, (US$ Million)

Overview
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
Hypothyroidism
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Male Hypogonadism
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Growth Hormone Deficiency
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Menopause
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

8. Global Hormone Replacement Therapy Market, By Distribution Channel, 2017 - 2030, (US$ Million)

Overview
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
Hospital Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Retail Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Online Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

9. Global Hormone Replacement Therapy Market, By Region, 2017 - 2030, (US$ Million)

Introduction
- Market Share Analysis, By Region, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, For Regions, 2017-2030
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Route Of Administration, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
U.S.
Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Route Of Administration, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Route Of Administration, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Route Of Administration, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Route Of Administration, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
GCC
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Route Of Administration, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2017 - 2030, (US$ Million)
North Africa
Central Africa
South Africa